173 related articles for article (PubMed ID: 37192611)
21. Advances in the treatment of neurofibromatosis-associated tumours.
Lin AL; Gutmann DH
Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
[TBL] [Abstract][Full Text] [Related]
22. New classification and approaches to the treatment of schwannomatosis.
Makashova ES; Zolotova SV; Absalyamova OV; Galkin MV; Petrokovskaya AV; Kozlov AV; Golanov AV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):104-109. PubMed ID: 37830475
[TBL] [Abstract][Full Text] [Related]
23. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
Karwacki MW; Woźniak W
Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
[TBL] [Abstract][Full Text] [Related]
24. [Polyneuropathy associated with neurofibromatosis].
Drouet A; Créange A
Rev Neurol (Paris); 2005 Mar; 161(3):275-83. PubMed ID: 15800448
[TBL] [Abstract][Full Text] [Related]
25. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR; Messiaen L; Legius E; Pancza P; Avery RA; Blakeley JO; Babovic-Vuksanovic D; Ferner R; Fisher MJ; Friedman JM; Giovannini M; Gutmann DH; Hanemann CO; Kalamarides M; Kehrer-Sawatzki H; Korf BR; Mautner VF; MacCollin M; Papi L; Rauen KA; Riccardi V; Schorry E; Smith MJ; Stemmer-Rachamimov A; Stevenson DA; Ullrich NJ; Viskochil D; Wimmer K; Yohay K; ; Huson SM; Wolkenstein P; Evans DG
Genet Med; 2022 Sep; 24(9):1967-1977. PubMed ID: 35674741
[TBL] [Abstract][Full Text] [Related]
26. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromatosis. Nosological considerations.
Badiu C; Stefanache F
Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):39-44. PubMed ID: 12089989
[TBL] [Abstract][Full Text] [Related]
28. Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis.
Farschtschi SC; Kluwe L; Schön G; Friedrich RE; Matschke J; Glatzel M; Weis J; Hagel C; Mautner VF
Brain Pathol; 2020 Mar; 30(2):386-391. PubMed ID: 31424590
[TBL] [Abstract][Full Text] [Related]
29. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
30. What to know about schwannomatosis: a literature review.
Schraepen C; Donkersloot P; Duyvendak W; Plazier M; Put E; Roosen G; Vanvolsem S; Wissels M; Bamps S
Br J Neurosurg; 2022 Apr; 36(2):171-174. PubMed ID: 33263426
[TBL] [Abstract][Full Text] [Related]
31. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.
Vasudevan HN; Payne E; Delley CL; John Liu S; Mirchia K; Sale MJ; Lastella S; Nunez MS; Lucas CG; Eaton CD; Casey-Clyde T; Magill ST; Chen WC; Braunstein SE; Perry A; Jacques L; Reddy AT; Pekmezci M; Abate AR; McCormick F; Raleigh DR
Nat Commun; 2024 Jan; 15(1):477. PubMed ID: 38216572
[TBL] [Abstract][Full Text] [Related]
32. Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.
Castellanos E; Plana A; Carrato C; Carrió M; Rosas I; Amilibia E; Roca-Ribas F; Hostalot C; Castillo A; Ros A; Quer A; Becerra JL; Salvador H; Lázaro C; Blanco I; Serra E; Bielsa I;
JAMA Dermatol; 2018 Mar; 154(3):341-346. PubMed ID: 29322178
[TBL] [Abstract][Full Text] [Related]
33. [Neurofibromatosis type 2].
Goutagny S; Bouccara D; Bozorg-Grayeli A; Sterkers O; Kalamarides M
Rev Neurol (Paris); 2007 Sep; 163(8-9):765-77. PubMed ID: 17878803
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
Plotkin SR; Bredella MA; Cai W; Kassarjian A; Harris GJ; Esparza S; Merker VL; Munn LL; Muzikansky A; Askenazi M; Nguyen R; Wenzel R; Mautner VF
PLoS One; 2012; 7(4):e35711. PubMed ID: 22558206
[TBL] [Abstract][Full Text] [Related]
35. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
[TBL] [Abstract][Full Text] [Related]
36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
Lasota J; Wasag B; Dansonka-Mieszkowska A; Karcz D; Millward CL; Ryś J; Stachura J; Sobin LH; Miettinen M
Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
[TBL] [Abstract][Full Text] [Related]
38. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis.
Merker VL; Bredella MA; Cai W; Kassarjian A; Harris GJ; Muzikansky A; Nguyen R; Mautner VF; Plotkin SR
Am J Med Genet A; 2014 Jun; 164A(6):1431-7. PubMed ID: 24664633
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis.
Gerber PA; Antal AS; Neumann NJ; Homey B; Matuschek C; Peiper M; Budach W; Bölke E
Eur J Med Res; 2009 Mar; 14(3):102-5. PubMed ID: 19380279
[TBL] [Abstract][Full Text] [Related]
40. The Diagnosis and Management of Neurofibromatosis Type 1.
Ly KI; Blakeley JO
Med Clin North Am; 2019 Nov; 103(6):1035-1054. PubMed ID: 31582003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]